Jiangsu Skyray Instrument Co., Ltd.
300165 · SZSE · China
skyray-instrument.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $24.27M, above the global median of $18.58M
- PositionDebt-to-equity is 1.05×, higher than 95% of its Scientific & Technical Instruments peers (median 0.13×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.92BCNY339.42M · vs all stocks (USD)
Revenue (TTM)
638.38MCNY92.57M · vs all stocks (USD)
Profit Margin
-27.87%vs Scientific & Technical Instruments peers
Beta
1.28xvs all stocks
52-Week Change
-12.61%vs all stocks
Market Capitalization
1.92BCNY339.42M · vs all stocks (USD)
Enterprise Value
2.98BCNY502.83M · vs all stocks (USD)
Forward P/E
11.76xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
3.01xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
1.75xvs Scientific & Technical Instruments peers
Enterprise to Revenue
4.67xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
-29.89xvs Scientific & Technical Instruments peers
Gross Margin
53.02%vs Scientific & Technical Instruments peers
Profit Margin
-27.87%vs Scientific & Technical Instruments peers
Operating Margin
-18.32%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
-2.30%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
-14.51%vs Scientific & Technical Instruments peers
Revenue (TTM)
638.38MCNY92.57M · vs all stocks (USD)
Revenue per Share (TTM)
1.27CNYUpdated Nov 22, 2026Quarterly Revenue Growth
14.80%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
266.97MCNY37.26M · vs all stocks (USD)
EBITDA (TTM)
63.88MCNY9.58M · vs all stocks (USD)
Net Income (TTM)
-177.93MCNY-30.54M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
308.40%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
184.64MCNY26.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
145.95MCNY24.27M · vs all stocks (USD)
5-Year Average Dividend Yield
0.34%vs all stocks
Payout Ratio
333.33%vs Scientific & Technical Instruments peers
Minority Interest (Equity)
38.24MCNYFY2025 · Dec 31, 2025Revenue
619.14MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
352.29MCNYFY2025 · Dec 31, 2025Gross Profit
266.86MCNYFY2025 · Dec 31, 2025Operating Income
1.45MCNY217.85K · vs all stocks (USD)
Pre-tax Income
-230.16MCNYFY2025 · Dec 31, 2025Income Tax Expense
11.22MCNYFY2025 · Dec 31, 2025Net Income
-241.37MCNYFY2025 · Dec 31, 2025EBIT
-172.71MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
63.88MCNYFY2025 · Dec 31, 2025Research & Development
41.59MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
79.26MCNYFY2025 · Dec 31, 2025Other Operating Expenses
10.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
34.24MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
57.45MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.4700CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.4700CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
495.39MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
495.39MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-241.37MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
8.54MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
22.93MCNYFY2025 · Dec 31, 2025Free Cash Flow
16.08MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
116.35MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-241.37MCNYFY2025 · Dec 31, 2025Other Non-cash Items
62.24MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
178.60MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
23.45MCNYFY2025 · Dec 31, 2025Capital Expenditures
6.84MCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
0.00CNYFY2025 · Dec 31, 2025Sale of Investments
75.06KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
6.92MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
117.52MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-234.87MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-57.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.32MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-177.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
495.51MSharesUpdated Nov 22, 2026Float Shares
361.41MSharesUpdated Nov 22, 2026% Held by Insiders
24.94%vs all stocks
% Held by Institutions
4.75%vs all stocks
Total Cash (MRQ)
129.83MCNY15.57M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2620CNYUpdated Nov 22, 2026Total Debt (MRQ)
1.15BCNY173.33M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.01xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
3.33xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
2.22CNYUpdated Nov 22, 2026Total Assets
3.01BCNY451.09M · vs all stocks (USD)
Total Current Assets
2.71BCNYFY2025 · Dec 31, 2025Total Liabilities
1.93BCNYFY2025 · Dec 31, 2025Total Non-current Assets
298.17MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.07BCNYFY2025 · Dec 31, 2025Total Current Liabilities
859.19MCNYFY2025 · Dec 31, 2025Cash
120.24MCNYFY2025 · Dec 31, 2025Cash Equivalents
642.59KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
120.88MCNYFY2025 · Dec 31, 2025Accounts Receivable
478.58MCNYFY2025 · Dec 31, 2025Inventory
292.72MCNYFY2025 · Dec 31, 2025Accounts Payable
360.38MCNYFY2025 · Dec 31, 2025Short-term Debt
137.95MCNYFY2025 · Dec 31, 2025Other Current Liabilities
33.64MCNYFY2025 · Dec 31, 2025Long-term Debt
1.05BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
12.61MCNYFY2025 · Dec 31, 2025Common Stock (Book)
495.51MCNYFY2025 · Dec 31, 2025Retained Earnings
-293.18MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.08BCNY162.02M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
3.87CNYUpdated Nov 22, 202652-Week High
9.11CNYUpdated Nov 22, 202652-Week Change
-12.61%vs all stocks
Beta
1.28xvs all stocks
50-Day MA
4.74CNYUpdated Nov 22, 2026200-Day MA
5.45CNYUpdated Nov 22, 2026Avg 10-Day Volume
11.35MSharesUpdated Nov 22, 2026Avg 30-Day Volume
15.15MSharesUpdated Nov 22, 2026Diluted EPS (TTM)
-0.3600CNYUpdated Nov 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 1.05×, higher than 95% of its Scientific & Technical Instruments peers (median 0.13×)Significant
Debt-to-equity: 1.05Industry median: 0.13Industry P95: 1.00Peers compared: 64.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.53Profit Margin: -0.33
Financial Health
Altman Z-Score 1.32: grey zoneSignificant
Altman Z-Score: 1.32
Low earnings qualitySignificant
Earnings Quality Score: -0.66
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Levered free cash flow is $24.27M, above the global median of $18.58MNotable
Levered free cash flow (USD): 24,269,785.896Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Ichia Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Everspin Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangsu Nanfang Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Zhejiang Yangfan New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Taiwan Paiho Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sunlour Pigment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
HLB Innovation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Osaki Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Ranpak Holdings Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tera Probe Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking